Using national electronic health record data from 174,678 patients with type 1 diabetes, we conducted a sequential target trial emulation from January 2013 to March 2024
nevertheless, additional studies would be suited to further corroborate the encouraging results presented by the current study, and to further widen the field of l-ARG supplementation clinical applicability
These details matter
Peptide Therapy: What You Need to Know Peptides are all over social media right now
Fourth, the analyses with dementia subtypes should be considered exploratory and interpreted with caution, because the diagnoses were not necessarily biomarker-confirmed, and the referent standard in the validation studies [38, 39] was not biomarker-confirmed diagnoses
Tilokani L, Nagashima S, Paupe V, Prudent J